Literature DB >> 17652062

Synovial sarcoma in children. A single centre experience.

L Moreno Martín-Retortillo1, M M Andrés Moreno, A Cañete Nieto, V Castel Sánchez.   

Abstract

Synovial sarcoma (SS) is a rare disease in the paediatric population, predominating in adolescents. Surgery remains the best treatment strategy for resectable cases. Adjuvant chemotherapy or radiotherapy can be used but have not proven efficacy. Metastatic disease and unsuccessful surgery are major prognostic factors. We describe four cases in children aged 7-13 years old. All of them were affected by SS of upper and lower limbs, and had satisfactory resections with different outcomes in spite of receiving diverse chemotherapy regimens. One of them is at the moment under treatment for relapse, two are disease-free and another died after metastatic disease.

Entities:  

Mesh:

Year:  2007        PMID: 17652062     DOI: 10.1007/s12094-007-0087-3

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  12 in total

Review 1.  Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies.

Authors:  Ines B Brecht; Andrea Ferrari; Christoph Int-Veen; Andreas Schuck; Adrian C Mattke; Michela Casanova; Gianni Bisogno; Modesto Carli; Ewa Koscielniak; Joern Treuner
Journal:  Pediatr Blood Cancer       Date:  2006-01       Impact factor: 3.167

Review 2.  Soft-tissue sarcomas in adults.

Authors:  Matthew A Clark; Cyril Fisher; Ian Judson; J Meirion Thomas
Journal:  N Engl J Med       Date:  2005-08-18       Impact factor: 91.245

3.  Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital.

Authors:  E L Spurrell; C Fisher; J M Thomas; I R Judson
Journal:  Ann Oncol       Date:  2005-01-14       Impact factor: 32.976

4.  Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital.

Authors:  S L Spunt; C A Poquette; Y S Hurt; A M Cain; B N Rao; T E Merchant; J J Jenkins; V M Santana; C B Pratt; A S Pappo
Journal:  J Clin Oncol       Date:  1999-12       Impact factor: 44.544

5.  Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study.

Authors:  C B Pratt; H M Maurer; P Gieser; A Salzberg; B N Rao; D Parham; P R Thomas; R B Marcus; A Cantor; T Pick; D Green; J Neff; J J Jenkins
Journal:  Med Pediatr Oncol       Date:  1998-04

6.  Is reexcision in pediatric nonrhabdomyosarcoma soft tissue sarcoma necessary after an initial unplanned resection?

Authors:  C H Chui; S L Spunt; T Liu; A S Pappo; A M Davidoff; B N Rao; S J Shochat
Journal:  J Pediatr Surg       Date:  2002-10       Impact factor: 2.545

7.  Localized unresectable non-rhabdo soft tissue sarcomas of the extremities in pediatric age: results from the Italian studies.

Authors:  Giovanni Cecchetto; Rita Alaggio; Patrizia Dall'Igna; Gianni Bisogno; Andrea Ferrari; Cosimo Gigante; Michela Casanova; Guido Sotti; Ilaria Zanetti; Modesto Carli
Journal:  Cancer       Date:  2005-11-01       Impact factor: 6.860

8.  Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment.

Authors:  A J Spillane; R A'Hern; I R Judson; C Fisher; J M Thomas
Journal:  J Clin Oncol       Date:  2000-11-15       Impact factor: 44.544

9.  High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas.

Authors:  B Kasper; T Lehnert; L Bernd; G Mechtersheimer; H Goldschmidt; A D Ho; G Egerer
Journal:  Bone Marrow Transplant       Date:  2004-07       Impact factor: 5.483

10.  Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome.

Authors:  Mehmet Fatih Okcu; Mark Munsell; Joern Treuner; Adrian Mattke; Alberto Pappo; Alvida Cain; Andrea Ferrari; Michela Casanova; Alp Ozkan; Beverly Raney
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.